Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2014

May 13, 2014

29828_dirs_2014-05-13_7acc382c-408c-4a1d-a039-6fc07a0aee58.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-05-10

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-10 Common Stock M 5000 Acquired 21290 Direct
2014-05-10 Common Stock F 2857 $79.76 Disposed 18433 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-10 Restricted Stock Unit $ M 5000 Disposed Common Stock (5000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F2: The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 25% every year thereafter until fully vested.